Cerebras IPO TrumpXi Summit Trade Talks and Automaker Layoffs Dominate Market Focus Transportation Secretary Duffys Reality Show Raises ConflictofInterest Questions Sponsors Include Firms Under His Agencys Watch Screen Time Backlash Parents Push for Less Tech in Schools but Administrators Say No Easy OptOut Is Snail SNAL Still a Buy After 1019 Rally 20260515 American Global Secures Lloyds Quota Share Reinsurance Deal Expanding Underwriting Capacity Manufacturing Energy and Carbon Footprints 2018 MECS Department of Energy Report Published SpaceX Postpones Starship Launch Amid Plans for RecordBreaking Stock Market Debut Indias Job Market Faces Headwinds as Iran Conflict Disrupts Remittances and Trade BSE and NSE to Observe Holiday on May 28 for Bakri Id Markets to Remain Closed Regaal Resources Reports 24 Revenue Growth to 1134 Crore in Fiscal Year 2026 CVBF Q1 2026 Earnings Slight EPS Miss Amid Stable Operations Shares Edge Higher Unicycive Therapeutics UNCY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development Senmiao Technology Limited AIHS Q1 2026 Earnings Narrowed Loss Amid Operational Challenges PDS Biotechnology Q1 2026 Earnings EPS Beat on Narrower Loss Clinical Progress in Focus Array Digital Infrastructure Inc AD Q1 2026 Earnings Massive EPS Beat Drives Optimism Amid Cautious Outlook PHAT Q1 2026 Earnings Missed EPS Estimates Amid Ongoing Development Efforts Republic Digital Acquisition Warrants RDAGW Hold Steady at 043 as Trading Remains RangeBound Four Corners Property Trust FCPT Edges Up 028 as Stock Holds Near MidRange Support HUHUTECH HUHU Plunges Over 16 as Selling Pressure Intensifies Key Support Levels in Focus Virtus AI Tech Opportunities Fund AIO Holds Steady Near Support After Modest Uptick Nano Dimension NNDM Declines 325 as Selling Pressure Intensifies Near Support Levels WORK Medical Technology WOK Experiences Continued Decline Falls 541 to 010 US Productivity Growth Moderates in Q4 as Labor Costs Rise What It Means for Inflation and Earnings SFL Q1 2026 Earnings Massive EPS Surprise of 1880 Despite Revenue Uncertainty NewAmsterdam Pharma NAMS Edges Higher as Shares Test Key Resistance Level